Hippophaea Rhamnoides Interferes With Insulin Release Via L-Type Ca2+ by JOANTA, Adela Elena et al.
 207  
Bulletin UASVM, Veterinary Medicine 66(1)/2009 
ISSN 1843-5270; Electronic ISSN 1843-5378 
 
 
Hippophaea Rhamnoides Interferes With Insulin Release Via L-Type Ca2+  
Channel-Mediated Pathway In Rat Islet Β-Cells 
  
Adela Elena JOANTA1), S.V. SARLEA1), C. LOGIN1), Carmen SOCACIU 2),  
N. DECEA1),  R. MOLDOVAN1), A. DAMIAN2) 
 
1)
“Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania 
2)University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania 
E-mail: adelaelena@yahoo.com 
 
 Running title: Hippophaea Rhamnoides and Calcium signaling in pancreatic β-cells.  
 
Abstract. Diabetes Mellitus continues to be a world public health problem, having a cascade of 
complications generated by the oxidative Stress induced by the hyperglycaemia. Our aim was to 
observe the Hippophaea rhamnoides extract involvement in insulin release via L-type Ca2+ channel-
mediated pathway and its antioxidant effect. 
 Experiments were performed on white, male, Wistar rats, organized as follows: group 1: 
control-standard diet, group 2: rats fed a diet enriched in sea buckthorne: (Hippophaea rhamnoides) in 
a high concentration and glucose, group 3: rats fed a diet enriched in sea buckthorne in a low 
concentration and glucose, group 4: rats treated with L-type Ca2+ channel blocker (Nifedipine), fed a 
diet enriched in sea buckthorn in a high concentration and glucose, group 5: rats treated with 
Nifedipine, fed a diet enriched in a low concentration and glucose, group 6: rats fed a diet enriched in 
glucose and group 7: rats fed a standard diet and treated with Nifedipine. Glycemia level, oxidative 
stress markers and antioxidant defense were assessed from pancreas after 10 days of experiment.  
 The high concentration of  Hippophaea rhamnoides and Nifedipine administration increased 
glycemia level and oxidative stress markers, probably through a long-lasting elevation of Ca2+, 
evoking the Ca2+ toxicity and consequent dysfunction of islet β-cells.  
Hippophaea rhamnoides interferes with insulin release via L-type Ca2+ channel-mediated 
pathway in rat islet β-cells. A new approach regarding fitotherapeutical alternatives in diabetes 
mellitus has to be considered.  
 




Diabetes Mellitus continues to be a world public health problem, having a cascade of 
complications such as cardiovascular disease, chronic renal failure, retinal damage, nerve 
damage, and microvascular damage, which may cause erectile dysfunction and poor healing 
of wounds. It is well known that oxidative stress, occurring as a consequence of 
hyperglycemia, plays a central role in the pathogenesis and progression of diabetes and its 
complications (Kowluru, 2000). 
 A possible role for intracellular calcium as a modulator of insulin secretion was 
originally proposed by Clausen et al. and Kissebach (1974). Later, it was demonstrated that 
diverse aspects of insulin action are dependent upon exta- and intracellular calcium 
concentration (Mc Donald, 1985). 
 Polyunsaturated fatty acids, such as oleic acid have an antioxidant effect, being found 
in high concentration in Hippophaea rhamnoides. LONG-CHAIN FREE FATTY ACIDS 
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(FFAs), as well as glucose, are the principal energy sources for the body. FFAs are also 
considered the systemic signals that link metabolic states to insulin release. Both stimulatory 
and inhibitory effects of FFAs on insulin secretion have been documented. In the short term, 
acute increases in circulating FFAs promote insulin secretion from pancreatic -cells (Gillery, 
1998; Moore, 2004). By contrast, when the plasma level of FFAs is chronically elevated, it 
inhibits insulin secretion, a phenomenon recognized as lipotoxicity (Mason,1999; Zhou,1994).  
 Our aim was to observe the Hippophaea rhamnoides extract involvement in insulin 
release via L-type Ca2+ channel-mediated pathway from rat islet β-cells and its antioxidant 
effect.  
MATERIALS AND METHODS 
 
Animals and housing conditions 
 Wistar rats, male, 90 days old, weighting 130-150g, were maintained under pathogen- 
free conditions in a temperature-controlled (23 ± 10C, 50-70% relative humidity) and light-
controlled (illuminated from 0600-1800 h) room. None of the animals died unexpectedly. All 
animal studies were done according to the local guidelines for animal research and principals 
of the European Convention for the Protection of Vertebrate Animals Used for Experimental 
and Other (published in the Official Daily N.L. 358/1-358/6, 18, December 1986).   
 
Experimental procedures 
 Experiments were performed on white, male, Wistar rats, organized as follows: 
• Group 1 (Gr1): control-standard diet; 
• Group 2 (Gr2): rats fed a standard diet enriched in sea buckthorne (Hippophaea 
rhamnoides:1000 mg/100 g body mass/day - high concentration) and hypertonic glucose; 
• Group 3 (Gr3): rats fed a standard diet enriched in sea buckthorne (Hippophaea 
rhamnoides: 500 mg/100 g body mass/day - low concentration) and hypertonic glucose; 
• Group 4 (Gr4): rats treated with L-type Ca2+ channel blocker (Nifedipine), fed a standard 
diet enriched in a high concentration in Hippophaea rhamnoides and hypertonic glucose;  
• Group 5 (Gr5): rats treated with Nifedipine, fed a standard diet enriched in a low 
concentration in Hippophaea rhamnoides and hypertonic glucose;  
• Group 6 (Gr6): rats fed a diet enriched in hypertonic glucose;  
• Group 7 (Gr7): rats fed a standard diet and treated with Nifedipine. 
    Experiments were performed during 10 days. Each experimental group consisted in 10 rats. 
 The animals diet was enriched in lipoprotein fraction from Hippophaea rhamnoides, 
separated by centrifugation at 2500 rotations/minute from the pulp raw juice (Pintea, 2001). 
 Hypertonic glucose (10%) was administered by gavages: 0,5 ml/100g/body mass/day 
and Nifedipine was intraperitoneally administered: 0,1 mg/100g body mass/day, 
corresponding to 60 mg/day which is the current dose of Nifedipine used as calcium 
antagonist in humans. 
 Glycemia level, oxidative stress markers (lipid peroxides) and antioxidant defence 
(superoxiddismutase) were assessed from the pancreatic tissue. 
 
Biochemical analysis 
 Blood was taken from the retro orbital sinus then animals were killed by decapitation 
under ether anesthesia. Glycemia level was assessed by an automatically biochemical 
analyzer KONELAB. 
 The pancreas was rapidly excised and placed into Petri dishes containing ice-cold 
isolation medium. Tissue homogenate was used for analytical procedures. Lipid peroxides and 
superoxiddismutase activity were assessed from the pancreas. Lipid peroxides were analyzed 
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measuring the production of thiobarbituric reactive substances (TBARS) using a fluorometric 
method. Results were expressed in nmol malondialdehyde (MDA)/mg protein (Joanta, 2006). 
Protein content was determined using bovine serum albumin as standard (Lowry, 1951). 
 Superoxiddismutase (SOD) activity in pancreas was assessed through Matkovics 
method with adrenaline. One unit (U) of SOD activity is the amount of protein required to 




 All results were expressed as the mean ± SEM (standard error of the mean). The data 
were processed by the Statistical Package for Social Sciences (SPSS), version 13.0 for 
Windows. Spearman’s rho correlations were used to determine the degree of association 
among selected variables. Data were analyzed using one way ANOVA test. Differences were 




The high concentration of Hippophaea rhamnoides (group 2) led to a significant 
increase in glycemia level (141 ± 1.66 mg %) as compared to the low concentration (group 3: 
100 ± 0.8 mg % ),  group 6 fed a diet enriched in hypertonic glucose (110 ± 3.33 mg %) and 
control (89 ± 1.92 mg %). This observation suggests that the hypoglycemic effect of the 
Hippophaea rhamnoides depends on the administered concentration: a high concentration  
decreased insulin release from β cells leading to an increase glycemia level found in group 2.  
Nifedipine administration determined a significant increase in glycemia level in group 
4 (180 ± 16 mg %) as compared to group 2 (141 ± 1.66  mg %) and group 7 (140 ±  6.33 mg 
% ), and in group 5 (138 ± 12.5 mg %) as compared to group 3 (100 ± 0.8 mg %), indirectly 
showing that Hippophaea rhamnoides stimulates insulin release via L-type Ca 2+ channel-
mediated pathway - table 1. 
Tab.1 
Glycemia level (mg %) 
Gr 1 89.8  ± 1.92 
Gr 2 141 ± 1.66 
Gr 3 100 ± 0.8 
Gr 4 180 ± 16 
Gr 5 138 ± 1.25 
Gr 6 110 ± 3.33 
Gr 7 140 ±  6.33 
                       Values are expressed as Mean ± SD;      - Group 2 versus group 3,  group 6 and group 1; 
                       Statistical analysis;                                  - Group 4 versus group 2 and group 7; 
                       P< 0.001;                                                 - Group 5 versus group 3. 
 
            A significant increase in pancreatic MDA levels (27.5 ± 2.03 nmol/mg protein) was 
noticed in animals fed a high concentration of Hippophaea Rhamnoides as compared to group 
fed a low concentration (15.93 ± 1.86 nmol/mg protein) and to group fed a diet enriched in 
hypertonic glucose (14 ± 2.33 nmol/mg protein), suggesting that Hippophaea Rhamnoides has 
a dual effect: antioxidant at a low concentration and prooxidant at a high one - table.2. 
The administration of both Hippophaea Rhamnoides in a high dose and Nifedipine led 
to a significant increase in pancreatic MDA levels - group 4 (40.5 ± 3.51 nmol/mg protein)  as 
compared to rats not treated with Nifedipine- group 2 (27.5 ± 2.03 nmol/mg protein) and to 
rats fed a standard diet and treated with Nifedipine - group 7 (31 ±  4.52 nmol/mg protein).  
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On the other hand, the administration of both Hippophaea Rhamnoides in a low dose and 
Nifedipine led to a significant increase in pancreatic MDA levels - group 5 (23.33 ± 1.74 
nmol/mg protein) as compared to rats not treated with Nifedipine - group 3 (15.93 ± 1.86 
nmol/mg protein) - table 2. 
Tab. 2 
MDA activity in pancreas (nmol/mg protein) 
Gr 1 10.66 ± 6.33 
Gr 2 27.5 ± 2.03 
Gr 3 15.93 ± 1.86 
Gr 4 40.5 ± 3.51 
Gr 5 23.33 ± 1.74 
Gr 6 14 ± 2.33 
Gr 7 31 ±  4.52 
                  Values are expressed as Mean ± SD          - Group 2 versus group 3,  group 6 and group 1; 
                  Statistical analysis                                      - Group 4 versus group 2 and group 7; 
                  P< 0.001                                                     - Group 5 versus group 3. 
                                                        
A significant decrease in pancreatic SOD levels (27 ± 3.39 U/mg protein) was noticed in 
animals fed a high concentration of Hippophaea Rhamnoides as compared to group fed a low 
concentration (42 ± 10.7 U/mg protein), to group fed a diet enriched in hypertonic glucose (44 
± 4.5 U/mg protein) and to control (41 ± 2.23 U/mg protein), suggesting that Hippophaea 
Rhamnoides has a dual effect: antioxidant at a low concentration and prooxidant at a high one. 
A low activity of SOD in group 2 suggests that the free radicals were scavenged by this 
enzyme - table 3.  
Tab. 3 
SOD activity in pancreas (U/mg protein) 
Gr 1 41 ± 2.23 
Gr 2 27 ± 3.39 
Gr 3 42 ± 10.7 
Gr 4 18.8 ± 6.84 
Gr 5 30 ± 5.66 
Gr 6 44 ± 4.5 
Gr 7 34 ± 7.66 
                    Values are expressed as Mean ± SD;       - Group 2 versus group 3, group 6 and group 1; 
                    Statistical analysis;                                   - Group 4 versus group 2 and group 7; 
                    P< 0.001;                                                  - Group 5 versus group 3. 
                                                                     .  
Analysis of Correlations. It was noticed significant correlations among the glycemia, MDA 
and SOD - table 4. 
Tab. 4  
Correlations among parameters 
Legend: ** Correlation is significant at the 0.001 level (2-tailed) 
 
glycemia MDA SOD 
Glycemia            Pearson Correlation 
                           Sig.(2-tailled) 










MDA                  Pearson Correlation 
                           Sig.(2-tailled) 










SOD                   Pearson Correlation 
                           Sig.(2-tailled) 














It is well known that chronic hyperglycemia leads to the auto-oxidation of glucose and 
causes the non enzymatic glycation of proteins through Maillard’s reaction (Gilery, 1998). In 
these processes, reactive oxygen species are produced. To avoid oxidative stress, antioxidant 
enzymes such as: catalase, superoxid dismutase and glutathione peroxidase play an important 
role against oxidative stress. However, hyperglycemia also causes nonenzymatic glycation of 
these antioxidant enzymes (Hundal, 2000). Hyperglycemia-induced oxidative stress plays a 
key role in the development of diabetes or its complications (Kowluru, 2000). 
Our aim was to explore the antioxidant effect of Hippophaea Rhamnoides (sea 
buckthorn) extract in different circumstances related to insulin release from rat islet β-cells 
and to explain its mechanism of action related to calcium signaling in pancreatic β-cells. Why 
did we choose Hippophaea Rhamnoides? The plant grows naturally in sandy soil at an 
altitude of 1.200-4.500 meters in cold climates, though it can be cultivated at lower altitudes 
and into temperate zones. The fruit consists in: vitamin C, vitamin E, folic acid, carotenoids,  
fatty acids (oleic, palmitoleic, palmitic, linoleic and linolenic acid), flavonoids (mainly 
isorhamnetin, quercetin glycosides, and kaempferol; these are the same flavonoids as found in 
Ginkgo biloba (Pintea, 2001).  In our experiment we used a high concentration (1000mg/100g 
body mass) and a low one (500mg/100g body mass) of Hippophaea Rhamnoides. The high 
concentration determined the highest level of glycemia, which, indirectly suggests, a decrease 
in insulin release from β cells. Also, it was noticed an increase in oxidative stress markers 
(MDA levels) and a decrease in antioxidant defense (SOD activity) corresponding to the 
highest glycemia level. For this reason, it is possible to affirm that Hippophaea Rhamnoides 
has an antioxidant effect in a low concentration and a prooxidant effect in a high one. We 
extrapolated that our findings could be explained through in vitro research (Fujiwara, 2005). 
LONG-CHAIN FREE FATTY ACIDS (FFAs), as well as glucose, are the principal energy 
sources for the body. FFAs are also considered the systemic signals that link metabolic states 
to insulin release. Both stimulatory and inhibitory effects of FFAs on insulin secretion have 
been documented. In the short term, acute increases in circulating FFAs promote insulin 
secretion from pancreatic -cells (Gravena, 2002; Greenough, 1967; Stein, 1997). By contrast, 
when the plasma level of FFAs is chronically elevated, it inhibits insulin secretion (Mason, 
1999; Moore, 2004; Zhou, 1994), a phenomenon recognized as lipotoxicity.  
Also, our results showed that a low concentration of Hippophaea Rhamnoides 
improved antioxidant defense through an increase in superoxiddismutase (SOD) activity 
which neutralized the reactive oxygen species produced by hyperglycemia.  
On the other hand, the administration of both Hippophaea Rhamnoides and Nifedipine 
led to a high level of glycemia and oxidative stress markers (MDA) as compared to group 
with and without Nifedipine and control. This observation indirectly suggests that 
Hippophaea Rhamnoides stimulates insulin release from the β cells through L-type Ca2+ 
channel-mediated pathway.  
The beneficial effects of the sea buckthorn and blueberry extract on antioxidant 
defense in type 1 diabetic children were reported by Nemes-Nagy et al (2008). Thirty type 1 
diabetic children were treated with a blueberry and sea buckthorn concentrate for two months. 
After two months of administering the product to diabetic children, the erythrocyte superoxide 
dismutase activity was significantly higher. Levels of glycated hemoglobin were significantly 
lower. The activity of whole blood glutathione peroxidase was moderately increased and C 
peptide concentration was significantly higher. 
 




Hippophaea rhamnoides initiates the insulin release mechanism via L-Type Ca2+ 
Channels and, also, it is involved in antioxidant defences. A higher concentration than 500 
mg/100g body mass/day induces Ca2+ and oxidative toxicity of the cell. The  sea-buckthorn 
extract is easy to obtain, it is not expensive, it decreases the oxidative damages in tissues and 
it determines insulin release, so it could be recommended as a phytotherapeutic product used 
in the daily diet of diabetes mellitus patients and for patients treated to Ca 2+ channel blockers.  
However, further in vivo and in vitro studies are definitely needed to clarify the 
beneficial dose of the Hippophaea rhamnoides regarding its involvement in insulin release 
and in antioxidant defence.  
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